Minimally invasive myocardial infarction model recapitulates patient immune responses and reveals a pathogenic role for immature neutrophils

This study establishes that a minimally invasive intact-chest myocardial infarction model more accurately replicates human immune responses than the standard open-chest approach by preserving bone marrow integrity, thereby revealing that the accumulation of immature neutrophils drives adverse cardiac remodeling.

The Gist

The Big Picture: A Flawed Map and a New Compass

Imagine scientists are trying to understand how the body heals after a heart attack. To do this, they use mice as "test subjects." For decades, the standard way to give a mouse a heart attack involved a major surgery: cutting open the chest, tying off a heart artery, and then sewing it back up.

This paper argues that this old method is like trying to study a forest fire while simultaneously setting off a massive fireworks display. The surgery itself causes so much trauma and stress that it confuses the results. It's hard to tell what is happening because of the heart attack versus what is happening because of the knife.

The authors introduce a new, minimally invasive method (the "intact-chest" model) that acts like a sniper shot rather than a sledgehammer. They show that this new method gives a much clearer, more accurate picture of what actually happens in human heart attacks, and they discovered a hidden "villain" in the healing process: immature white blood cells.

---

1. The Problem with the Old Method (The "Open-Chest" Model)

The Analogy: Think of the bone marrow (where blood cells are made) as a factory. Under normal conditions, the factory only ships out fully trained, "mature" soldiers (neutrophils) to fight infection.

In the old "open-chest" surgery:

• The trauma of cutting the chest is so severe that the factory goes into panic mode.
• It stops training new soldiers and frantically dumps everything it has into the bloodstream, including raw recruits (immature neutrophils) who aren't ready for battle.
• The Result: When scientists looked at the mice, they saw a massive army of raw recruits. They thought this was caused by the heart attack. But actually, it was caused by the surgery itself. The surgery masked the true story of the heart attack.

2. The Solution: The "Intact-Chest" Model

The Analogy: The new method is like using a remote-controlled drone to deliver a precise strike to the heart artery without opening the chest.

• Because the chest isn't cut, the body doesn't go into panic mode.
• The "factory" (bone marrow) stays calm. It only releases a small, manageable number of raw recruits.
• The Match: This small, controlled response looks exactly like what happens in human patients after a heart attack. This proves the new model is the "real deal" for studying human disease.

3. The Discovery: The "Immature Neutrophils"

Once they had the clean model, the scientists could finally see what was really happening. They found that even in a "calm" heart attack, the body does send some raw recruits (immature neutrophils) to the heart.

The Analogy: Imagine a construction site (the damaged heart) needs cleanup crews.

• Mature Neutrophils are like professional demolition experts. They know exactly what to do: clear the debris, clean up the mess, and help rebuild.
• Immature Neutrophils are like untrained volunteers who show up with sledgehammers. They are eager to help, but they are clumsy.

What the paper found:

• These "untrained volunteers" (immature neutrophils) can do some work (they can eat bacteria and release chemicals), but they are less efficient at cleaning up the mess than the pros.
• Worse, because they are clumsy, they cause collateral damage. They release too much "chemical fire" (oxidative stress) that hurts the healthy heart muscle around the injury.
• The Outcome: The more of these immature cells that show up, the worse the heart heals. The heart gets bigger, weaker, and scarred.

4. The Experiment: Making it Worse on Purpose

To prove that these immature cells were the problem, the scientists gave a group of mice a drug (G-CSF) that acts like a megaphone, shouting to the bone marrow factory: "Send more raw recruits! Send them all!"

• Result: The mice with the "megaphone" had a flood of immature neutrophils in their hearts.
• Consequence: Their hearts healed much worse than the control group. They had larger scars and weaker pumping power.
• Conclusion: It's not just having these cells; it's having too many of them that causes long-term heart failure.

5. Why This Matters for Humans

The paper connects the dots to real life:

• The Old Model was lying to us: Many past studies using the "open-chest" model might have been studying the effects of surgery, not the heart attack. This explains why some drugs that worked in mice failed in human trials.
• The New Model is the Truth: The "intact-chest" model shows us that in humans, the body sends a moderate amount of immature cells.
• The Takeaway: If we can find a way to stop the body from sending too many of these clumsy "untrained volunteers" to the heart after a heart attack, we might be able to prevent heart failure and save lives.

Summary in One Sentence

This paper swaps a messy, confusing way of studying heart attacks for a clean, accurate one, revealing that the body's own "untrained" immune cells can accidentally make heart damage worse, offering a new target for future treatments.

Technical Summary

1. Problem Statement

Myocardial infarction (MI) triggers a systemic inflammatory response, particularly involving neutrophils. While clinical data indicates that MI patients exhibit elevated levels of circulating immature neutrophils (a "left shift"), the specific roles of these subsets in cardiac remodeling remain unclear.

• The Gap: Most preclinical studies rely on the standard open-chest MI (oc-MI) model. However, this model involves invasive thoracotomy, which induces severe surgical trauma.
• The Hypothesis: The authors hypothesize that the surgical trauma inherent in the oc-MI model disrupts bone marrow (BM) homeostasis and triggers "emergency granulopoiesis" independently of the MI itself. This confounds the study of MI-specific immune mechanisms and fails to accurately mirror the moderate immune response seen in human patients.

2. Methodology

The study employed a comparative approach using human clinical data and two distinct murine models:

• Human Cohort: Peripheral blood samples from 13 patients with Acute MI (AMI) and 5 healthy donors were analyzed via flow cytometry to establish the baseline profile of circulating neutrophils (mature vs. immature) in humans.
• Murine Models:
  • Open-Chest MI (oc-MI): Standard invasive surgery involving thoracotomy and permanent ligation of the Left Anterior Descending (LAD) artery.
  • Intact-Chest MI (ic-MI): A minimally invasive model where LAD occlusion is induced via high-frequency electrical coagulation under echocardiographic guidance, avoiding thoracotomy.
• Experimental Groups: Both models included MI and Sham-operated (SO) controls.
• Key Techniques:
  • Flow Cytometry: To quantify neutrophil subsets (defined by CD101, CD10, CD16, Ly6G) in blood, bone marrow, and infarcted hearts.
  • Cytokine Profiling: Multiplex immunoassays and ELISA to measure G-CSF, CXCL1, IL-6, TNFα, and CCL2.
  • Functional Assays: Reactive Oxygen Species (ROS) production (DHR123) and phagocytosis (pHrodo) assays on sorted neutrophils.
  • Intervention: Administration of G-CSF/anti-G-CSF antibody complexes to selectively increase immature neutrophil recruitment in the ic-MI model.
  • Outcome Assessment: Echocardiography (LVEF, GLS, volumes), histology (Masson's Trichrome for fibrosis/scar size), and gene expression analysis (Nppa, Myh6, Myh7, Il6) at 28 days post-MI.
  • Spatial Mapping: Utilization of Sequential Immunofluorescence (SeqIF) to visualize neutrophil localization within the heart tissue.

3. Key Contributions

1. Validation of the Intact-Chest Model: The study provides the first comprehensive immunological validation that the ic-MI model faithfully recapitulates human neutrophil dynamics, whereas the oc-MI model does not.
2. Mechanism of Immature Neutrophil Mobilization: The authors demonstrate that MI induces a rapid, transient mobilization of pre-existing immature neutrophils from the bone marrow (driven by early G-CSF/IL-6 spikes) rather than sustained emergency granulopoiesis.
3. Pathogenic Role of Immature Neutrophils: The study establishes a causal link between elevated immature neutrophil counts and adverse cardiac remodeling, identifying them as active mediators of maladaptation rather than passive bystanders.
4. Re-evaluation of Immune Landscapes: The paper reveals that the immune cell composition (monocytes, macrophages, T/B cells) in the infarcted heart differs significantly between the two models, suggesting previous literature based on oc-MI may have mischaracterized post-MI immunity.

4. Key Results

A. Human vs. Mouse Model Comparison

• Human Data: AMI patients showed a ~10% increase in circulating immature (CD10⁻) neutrophils (vs. ~1% in healthy donors), with a modest rise in mature neutrophils.
• Open-Chest (oc-MI) Failure:
  • Surgical trauma alone (sham) caused a massive "left shift," with immature neutrophils comprising up to 80% of circulating neutrophils at 24h.
  • Bone marrow was virtually depleted of mature neutrophils and replaced by immature cells.
  • Systemic cytokines (G-CSF, CXCL1, IL-6) were drastically elevated due to surgery, masking MI-specific signals.
• Intact-Chest (ic-MI) Success:
  • Recapitulated the human profile: A modest, consistent increase in circulating immature neutrophils (~32% peak at 12h) without massive BM depletion.
  • No significant cytokine elevation in sham controls; cytokine spikes (G-CSF, IL-6) were transient and peaked at 4h post-MI.
  • Bone marrow homeostasis was preserved.

B. Neutrophil Dynamics and Function

• Kinetics: In the ic-MI model, cytokine spikes at 4h led to neutrophil egress from the BM at 12h, with peak infiltration into the heart at 12–24h.
• Spatial Distribution: Immature neutrophils infiltrated the infarct core, border zone, and were notably found beneath the endocardium and adjacent to the epicardium, suggesting multiple entry routes.
• Functionality: Infiltrated immature neutrophils were functionally competent:
  • Generated ROS levels comparable to mature neutrophils.
  • Exhibited phagocytic capacity (though slightly lower than mature cells).

C. Impact of Immature Neutrophils on Remodeling

• G-CSF Intervention: Treating ic-MI mice with G-CSF complexes increased immature neutrophil recruitment to the heart.
• Adverse Outcomes: High immature neutrophil counts correlated with:
  • Worsened Cardiac Function: Reduced LVEF and Global Longitudinal Strain (GLS).
  • Ventricular Dilation: Increased LVEDV and LVESV (large effect sizes despite p-values > 0.05).
  • Pathological Remodeling: Increased scar size, fibrosis, and upregulation of stress markers (Nppa, Myh7) and inflammation (Il6) at 28 days.

D. Broader Immune Landscape

• The ic-MI model showed distinct kinetics for other leukocytes compared to oc-MI:
  • Monocytes: More abundant in ic-MI at Day 1.
  • Macrophages: Dramatically increased in oc-MI at Days 5–7, but stable in ic-MI.
  • Lymphocytes: T and B cell accumulation was significantly higher and delayed in oc-MI compared to the minimal recruitment seen in ic-MI.

5. Significance

• Translational Relevance: The study argues that the widely used open-chest model induces a confounding "surgical inflammation" that leads to false positives in preclinical trials. Therapies targeting "emergency granulopoiesis" (common in oc-MI) may fail in humans because actual MI triggers only a mobilization of existing reserves.
• Clinical Implications: The findings validate circulating immature neutrophils as a biomarker for risk stratification (correlating with mortality in patients) and suggest that targeting the recruitment or function of these specific subsets could improve post-MI outcomes.
• Methodological Shift: The authors advocate for the adoption of minimally invasive models (like ic-MI) to ensure that preclinical immune profiling accurately reflects human pathophysiology, thereby increasing the success rate of translating immunotherapies to the clinic.